Skip to main content

Travere Therapeutics, Inc 10-Q for FY2024 Q2

Travere Therapeutics, Inc. (TVTX)

10-Q 2024-08-01 For: 2024-06-30
View Original
Added on April 07, 2026

About this 10-Q

Travere Therapeutics, Inc filed this 10-Q on August 1, 2024, covering the quarter ended June 30, 2024 (FY2024 Q2).

Headline figures

Quarter ended June 30, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$54.12M
up 68.1% from $32.2M a year earlier
Net loss
$70.41M
compared with a net loss of $85.63M a year earlier
Diluted EPS
-$0.91
compared with -$1.13 a year earlier